← Back to Clinical Trials
Recruiting NCT07338006

NCT07338006 Chest Wall Reconstruction Cohort

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07338006
Status Recruiting
Phase
Sponsor University of Health Sciences Lahore
Condition Chest Wall Tumor
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2021-01-01
Primary Completion 2026-12-31

Trial Parameters

Condition Chest Wall Tumor
Sponsor University of Health Sciences Lahore
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-01-01
Completion 2026-12-31
Interventions
chest wall reconstructionChest wall reconstruction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Chest wall reconstruction following tumor or infection-related resections remains a challenging aspect of thoracic surgery, requiring restoration of structural stability and preservation of respiratory mechanics. While polymethyl methacrylate (PMMA) bone cement has long been used for rigid reconstruction, its limitations-including high cost, rigidity, infection risk, and interference with normal respiratory motion-pose challenges in resource-constrained settings. Twisted stainless steel wires offer a low-cost, flexible alternative that allows dynamic chest wall movement and easier adaptability in low- and middle-income countries such as Pakistan. To compare postoperative outcomes, complications, and cost-effectiveness of chest wall reconstruction using twisted stainless steel wires versus PMMA bone cement over a two-year period (January 2025 - December 2026). This prospective cohort study was conducted in the Department of Thoracic Surgery, Services Hospital, Lahore, a high-volume tertiary care and referral center. Patients undergoing chest wall reconstruction following resection for tumors, infections, or trauma were enrolled and divided into two groups based on the reconstruction technique used: Group A (twisted steel wires) and Group B (PMMA bone cement). Parameters assessed included postoperative pain (VAS scores), respiratory function, chest wall stability, complications (infection, wound dehiscence, prosthesis exposure), duration of hospital stay, readmission rate, and cost of reconstruction. Data were analyzed to compare clinical and functional outcomes between both cohorts.

Eligibility Criteria

Inclusion Criteria: * Patients aged ≥18 years undergoing partial or full-thickness chest wall resection. * Defects requiring rigid or semi-rigid reconstruction involving two or more ribs or the sternum. Exclusion Criteria: * Patients with small defects managed by primary closure or soft tissue-only reconstruction. * Patients with concurrent major intrathoracic resections (e.g., pneumonectomy) may confound postoperative respiratory assessment. * Recurrent disease requiring revision reconstruction. * Patients unwilling or unable to provide consent or comply with follow-up.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology